Jacek Hajda

Years Active: 2017-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Jacek Hajda, Barbara Leuchs, Assia L Angelova, Veronika Frehtman, Jean Rommelaere, Mieke Mertens, Maximilian Pilz, Meinhard Kieser, Ottheinz Krebs, Michael Dahm, Bernard Huber, Christine E Engeland, Athanasios Mavratzas, Nicolas Hohmann, Jutta Schreiber, Dirk Jäger, Niels Halama, Oliver Sedlaczek, Matthias M Gaida, Volker Daniel, Christoph Springfeld, Guy Ungerechts
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Jacek Hajda, Monika Lehmann, Ottheinz Krebs, Meinhard Kieser, Karsten Geletneky, Dirk Jäger, Michael Dahm, Bernard Huber, Tilman Schöning, Oliver Sedlaczek, Albrecht Stenzinger, Niels Halama, Volker Daniel, Barbara Leuchs, Assia Angelova, Jean Rommelaere, Christine E Engeland, Christoph Springfeld, Guy Ungerechts
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol. BMC cancer 17 (1) (2017)

Jacek Hajda.css-eqlu8i{font-size:small;padding-left:4px;}